Biotherapeutics Distributor BDI Pharma, Inc. (Formerly known as Blood Diagnostics, Inc.) Offers New Online Product Catalog

COLUMBIA, SC--(Marketwire - July 20, 2009) -

Highlighted Links

www.ivig.com

www.bdipharma.com

BDI Pharma, Inc. (BDI), the nation's fastest growing distributor of specialty biotherapeutics, announced on July 1st the addition of an online product catalog, available for download on the company's corporate website. The new platform, to be updated quarterly, was created in accord with the company's focus on providing customers with a growing portfolio of solutions, specifically in this instance access to a full line product list.

"Not only does the BDI Pharma Online Product Catalog keep the healthcare community abreast of the growing list of products available from BDI, it also creates yet another venue for the company's manufacturing trade partners to promote their goods and services," said Brad Davis, Director of Marketing for BDI. "We at BDI Pharma are proud of our proactive style of doing business. We are always looking for new ways to provide a greater benefit to the medical provider, the manufacturer and, ultimately to our mutual customer, the patient. Doing so creates a winning situation for all parties."

About BDI Pharma, Inc.

Serving the healthcare community since 1995, BDI Pharma, Inc. has built an outstanding reputation as an industry source for products and service. BDI Pharma's market focus is evident in its commitment to specialty biotherapeutics, chemotherapies, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it supplies nationwide, BDI Pharma, Inc. services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI Pharma, Inc. defines its customer-centric approach to serving the nation's healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI Pharma, Inc.'s educational literature and Web site -- www.bdipharma.com -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.